Examkin

Soru

Zorluk: ZorInfectious Diseases

A 35-year-old man with untreated HIV infection is brought to the emergency department by his partner due to a 2-week history of progressively worsening headache, fever, and confusion. His temperature is 38.6°C (101.5°F), blood pressure is 120/78 mmHg, and heart rate is 102/min. Physical examination reveals nuchal rigidity and bilateral sixth cranial nerve palsies. Laboratory studies show a CD4 cell count of 28/mm³. A lumbar puncture is performed, and cerebrospinal fluid (CSF) analysis reveals a leukocyte count of 350/mm³ (85% lymphocytes), glucose of 30 mg/dL, and protein of 150 mg/dL. CSF acid-fast bacilli smear is positive. The patient is admitted to the intensive care unit and started on isoniazid, rifampin, pyrazinamide, ethambutol, and intravenous dexamethasone. Which of the following is the most appropriate timing for initiating antiretroviral therapy in this patient?

  1. A
    Concurrently with the initiation of anti-tuberculous therapy
  2. B
    Within 2 weeks of starting anti-tuberculous therapy
  3. C
    At approximately 4 weeks after starting anti-tuberculous therapy
  4. At approximately 8 weeks after starting anti-tuberculous therapyCevap
  5. E
    After completion of the entire 9- to 12-month anti-tuberculous regimen

Cevap

At approximately 8 weeks after starting anti-tuberculous therapy
The correct timing is to delay ART for approximately 8 weeks. In patients with HIV who develop tuberculous meningitis, initiating antiretroviral therapy (ART) early leads to a rapid restoration of immune function. This robust inflammatory response directed against mycobacterial antigens in the central nervous system is known as Immune Reconstitution Inflammatory Syndrome (IRIS). In the closed space of the skull, the resulting edema can cause severe neurological deterioration, herniation, and death. Therefore, current guidelines mandate delaying ART for at least 8 weeks in all patients with TB meningitis, regardless of how low their CD4 cell count is.

Adım Adım Çözüm

1
Identify the patient's primary diagnosis and immune status.
The patient has tuberculous (TB) meningitis and advanced HIV with a CD4 count of 28/mm³.
CSF findings (lymphocytic pleocytosis, low glucose, high protein) with a positive AFB smear in an HIV-positive patient confirm TB meningitis. The CD4 count dictates HIV severity.
2
Determine the standard rules for antiretroviral therapy (ART) initiation in HIV-TB coinfection.
Generally, for pulmonary TB, ART is started within 2 weeks if CD4 < 50/mm³, and within 8 weeks if CD4 ≥ 50/mm³.
Early ART in pulmonary TB reduces HIV-related mortality, though it carries a risk of immune reconstitution inflammatory syndrome (IRIS).
3
Apply the specific exception for central nervous system (CNS) tuberculosis.
Because the patient has TB meningitis, the standard CD4-based rule is superseded. ART must be delayed for approximately 8 weeks.
CNS-IRIS in the closed space of the cranial vault can cause severe cerebral edema and herniation. Clinical trials have shown that early ART in TB meningitis increases mortality.

Anahtar Kavram

In patients with HIV and tuberculous meningitis, antiretroviral therapy (ART) should be delayed for approximately 8 weeks after starting anti-tuberculous therapy, regardless of the CD4 count, to prevent fatal CNS immune reconstitution inflammatory syndrome (IRIS).
Bu soruyu puanla

Konular

Infectious Diseases

Bu konudan daha fazla soru